Alimera Sciences, Inc. Profile Avatar - Palmy Investing

Alimera Sciences, Inc.

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular ed…

Drug Manufacturers - Specialty & Generic
US, Alpharetta [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of ALIM's Analysis
CIK: 1267602 CUSIP: 016259202 ISIN: US0162592028 LEI: - UEI: -
Secondary Listings
ALIM has no secondary listings inside our databases.